((自动化翻译由路透提供，请见免责声明 ))
11月27日 - ** 摩根大通将生命科学房地产投资信托公司亚历山大房地产股票 的评级从 "增持 "下调至 "中性"
** 将目标价从 133 美元下调至 121 美元，与该股上次收盘价相比仍有 8%以上的上涨空间
** 称 ARE 在生命科学领域的领先地位将在短期内被较低的增长所抵消
** 生命科学领域的空间需求一直疲软，尽管似乎已经触底，但在新建筑达到创纪录水平后，仍有供应需要消化"--券商
** 五家券商给予该股 "买入 "或更高评级，九家券商给予该股 "持有 "评级；他们的预测中值为 121 美元--LSEG 数据
** 截至上次收盘，该股今年已下跌约 12
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.